Medical Robotics Market Report 2026

The medical robotics market size has grown exponentially in recent years. It will grow from $16.73 billion in 2025 to $20.11 billion in 2026 at a compound annual growth rate (CAGR) of 20.2%. The growth in the historic period can be attributed to minimally invasive surgery demand, surgeon precision requirements, aging population needs, hospital automation adoption, rehabilitation therapy growth.

The medical robotics market size is expected to see exponential growth in the next few years. It will grow to $41.97 billion in 2030 at a compound annual growth rate (CAGR) of 20.2%. The growth in the forecast period can be attributed to AI-driven surgical innovation, healthcare digitization, shortage of skilled surgeons, demand for patient-centric care, expansion of tele-surgery. Major trends in the forecast period include expansion of robotic-assisted surgeries, adoption of ai-enabled surgical systems, growth of rehabilitation robotics, integration of data-driven healthcare automation, rising use in minimally invasive procedures.

The increasing prevalence of chronic diseases such as cardiovascular conditions is expected to drive the growth of the medical robotics market in the coming years. Cardiovascular diseases (CVDs) are a group of disorders caused by issues affecting the circulatory system, including the heart and blood vessels (arteries, veins, and capillaries). Medical robots support the treatment of circulatory diseases by enabling minimally invasive procedures, such as robot-assisted cardiac surgeries, which enhance precision and reduce patient trauma. For example, in January 2023, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, projected that by 2050, the number of people aged 50 and above with at least one chronic illness would rise by 99.5%. Therefore, the increasing prevalence of chronic diseases such as cardiovascular conditions is contributing to the expansion of the medical robotics market.

Major companies in the medical robotics market are focusing on innovative products, particularly robotic platforms, to better serve their existing consumers. A robotic solution refers to a comprehensive application or solution that utilizes robotic technology to address specific tasks, issues, or demands. For example, in May 2023, Robocath, a France-based company specializing in medical robotic solutions for heart-related diseases, introduced an innovative robotic platform called the R-One+. The R-One+ robotic system enables interventional cardiologists to perform coronary angioplasties by controlling the devices using a centralized command unit in the cathlab or control room. This approach offers two key advantages: it protects the cardiologist and medical staff from radiation-related risks, and it streamlines and secures the PCI (Percutaneous Coronary Intervention) process. Cardiologists can now perform more precise hand movements in more ergonomic working environments, ultimately benefiting patients. This focus on advanced robotic platforms reflects the industry's commitment to enhancing medical procedures and outcomes through robotic technology.

In April 2023, CardioVentures Inc., a UK-based medical device company, merged with AVRA Medical Robotics Inc. for an undisclosed sum. Following the merger, AVRA Medical Robotics aims to allocate a significant portion of its resources to expanding and reinforcing the operations of SSI-India, which will become the company's indirect majority-owned subsidiary. As part of this transition, the company's name has been changed to SS Innovations International, Inc. AVRA Medical Robotics Inc. is known for developing medical robot software and artificial intelligence.

Major companies operating in the medical robotics market are Johnson & Johnson, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, GE Healthcare, Philips Healthcare, Boston Scientific Corporation, Intuitive Surgical, Smith & Nephew plc, Varian Medical Systems, Omnicell, Globus Medical, Hansen Medical, Renishaw plc, Accuray Inc., Kinova Robotics, Hocoma AG, Titan Medical Inc., Ekso Bionics, TransEnterix Inc., ReWalk Robotics, Houston Medical Robotics, Medrobotics Corporation.

North America will be the largest region in the medical robotics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical robotics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical robotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical robotics market consists of sales of surgical robots / robot-assisted surgery machine, rehabilitation robots, laboratory robots, hospital robots, social robots. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.